New medical technology figure on European Commission vows to cut red tape:
This article was originally published in Clinica
Executive Summary
Gunter Verheugen, the new Commissioner for industry and enterprise at the European Commission, whose brief includes overseeing the Commission's medical device and diagnostics unit, has spoken out in support of a new bid by the European Council to cut red tape. During a meeting of economy ministers for a competitiveness council, held on November 25, ministers agreed to simplify existing regulations in several areas including healthcare, social policy and the environment. Mr Verheugen said that the fight against EU bureaucracy is a key priority for him and that he hopes it will become his "personal trademark over the next five years".
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.